Methods of treating diabetic retinopathy with pericyte apoptosis inhibitors
US8119609B2 · kind B2 · utility
0Cited by
6References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 23, 2003 |
| Grant date | Feb 21, 2012 |
| Priority date | — |
| Expiry date | Apr 23, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of preventing or treating diabetic retinopathy is disclosed including administering to a mammal a therapeutically effective amount of an inhibitor of retinal pericyte apoptosis. Also disclosed is a pharmaceutical composition which treats and/or prevents diabetic retinopathy comprising as an active agent a therapeutically effective amount of at least one inhibitor of retinal pericyte apoptosis and a pharmaceutically acceptable carrier.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.